Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Companion Animal Arthritis Market, by Indication
1.4.2 Europe Companion Animal Arthritis Market, by Distribution Channel
1.4.3 Europe Companion Animal Arthritis Market, by Treatment
1.4.4 Europe Companion Animal Arthritis Market, by Animal Type
1.4.5 Europe Companion Animal Arthritis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Companion Animal Arthritis Market by Indication
3.1 Europe Osteoarthritis Market by Country
3.2 Europe Other Arthritis Market by Country
Chapter 4. Europe Companion Animal Arthritis Market by Distribution Channel
4.1 Europe Veterinary Hospitals & Clinics Market by Country
4.2 Europe Retail Pharmacies Market by Country
4.3 Europe Online Stores Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe Companion Animal Arthritis Market by Treatment
5.1 Europe Medication Market by Country
5.2 Europe Supplements Market by Country
5.3 Europe Other Treatment Market by Country
Chapter 6. Europe Companion Animal Arthritis Market by Animal Type
6.1 Europe Dogs Market by Country
6.2 Europe Cats Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Companion Animal Arthritis Market by Country
7.1 Germany Companion Animal Arthritis Market
7.1.1 Germany Companion Animal Arthritis Market by Indication
7.1.2 Germany Companion Animal Arthritis Market by Distribution Channel
7.1.3 Germany Companion Animal Arthritis Market by Treatment
7.1.4 Germany Companion Animal Arthritis Market by Animal Type
7.2 UK Companion Animal Arthritis Market
7.2.1 UK Companion Animal Arthritis Market by Indication
7.2.2 UK Companion Animal Arthritis Market by Distribution Channel
7.2.3 UK Companion Animal Arthritis Market by Treatment
7.2.4 UK Companion Animal Arthritis Market by Animal Type
7.3 France Companion Animal Arthritis Market
7.3.1 France Companion Animal Arthritis Market by Indication
7.3.2 France Companion Animal Arthritis Market by Distribution Channel
7.3.3 France Companion Animal Arthritis Market by Treatment
7.3.4 France Companion Animal Arthritis Market by Animal Type
7.4 Russia Companion Animal Arthritis Market
7.4.1 Russia Companion Animal Arthritis Market by Indication
7.4.2 Russia Companion Animal Arthritis Market by Distribution Channel
7.4.3 Russia Companion Animal Arthritis Market by Treatment
7.4.4 Russia Companion Animal Arthritis Market by Animal Type
7.5 Spain Companion Animal Arthritis Market
7.5.1 Spain Companion Animal Arthritis Market by Indication
7.5.2 Spain Companion Animal Arthritis Market by Distribution Channel
7.5.3 Spain Companion Animal Arthritis Market by Treatment
7.5.4 Spain Companion Animal Arthritis Market by Animal Type
7.6 Italy Companion Animal Arthritis Market
7.6.1 Italy Companion Animal Arthritis Market by Indication
7.6.2 Italy Companion Animal Arthritis Market by Distribution Channel
7.6.3 Italy Companion Animal Arthritis Market by Treatment
7.6.4 Italy Companion Animal Arthritis Market by Animal Type
7.7 Rest of Europe Companion Animal Arthritis Market
7.7.1 Rest of Europe Companion Animal Arthritis Market by Indication
7.7.2 Rest of Europe Companion Animal Arthritis Market by Distribution Channel
7.7.3 Rest of Europe Companion Animal Arthritis Market by Treatment
7.7.4 Rest of Europe Companion Animal Arthritis Market by Animal Type
Chapter 8. Company Profiles
8.1 Boehringer Ingelheim International Gmbh
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expenses
8.2 Dechra Pharmaceuticals PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental & Regional Analysis
8.2.4 Research & Development Expenses
8.3 Elanco Animal Health, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Zoetis, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Geographical Expansions:
8.5 Vetoquinol SA (Soparfin SCA)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.6 Virbac
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 Ceva Santé Animale
8.7.1 Company Overview
8.8 Eltech K-Laser s.r.l.
8.8.1 Company Overview
8.9 Norbrook Laboratories Limited
8.9.1 Company Overview
8.10. NexGen Pharmaceuticals, LLC
8.10.1 Company Overview
Unique Offerings 
